Propanc Biopharma, Inc. (PPCB)
0.1916
-0.01
(-5.48%)
USD |
NASDAQ |
Feb 20, 16:00
0.19
0.00 (0.00%)
After-Hours: 20:00
Propanc Biopharma EPS Diluted (Quarterly) : -0.3012 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lumos Diagnostics Holdings Ltd. | -- |
| Incannex Healthcare, Inc. | -0.0187 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.091M |
| Total Expenses (Quarterly) | 3.091M |
| Enterprise Value | 3.649M |
| Earnings Yield | -7.07K% |
| Normalized Earnings Yield | -7030.01 |